Trial Profile
A Phase III, double-blind, randomised, multicenter trial comparing the safety and efficacy of fixed dose combination tablets of arterolane maleate and piperaquine phosphate (PQP) with Coartem® (artemether-lumefantrine tablets) in patients with acute uncomplicated Plasmodium falciparum malaria
Status:
Completed
Phase of Trial:
Phase III/IV
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Arterolane/piperaquine (Primary) ; Artemether/lumefantrine
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors Ranbaxy Laboratories
- 02 Mar 2016 New trial record
- 12 Feb 2016 Results published in the Clinical Infectious Diseases.